Ansprenger, C., Amberger, D. C., & Schmetzer, H. M. (2020). Potential of immunotherapies in the mediation of antileukemic responses for patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) - With a focus on Dendritic cells of leukemic origin (DCleu). Clinical immunology (Orlando, Fla.), 217, 108467. https://doi.org/10.1016/j.clim.2020.108467
Style de citation ChicagoAnsprenger, Christian, Daniel Christoph Amberger, et Helga Maria Schmetzer. "Potential of Immunotherapies in the Mediation of Antileukemic Responses for Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) - With a Focus on Dendritic Cells of Leukemic Origin (DCleu)." Clinical Immunology (Orlando, Fla.) 217 (2020): 108467. https://dx.doi.org/10.1016/j.clim.2020.108467.
Style de citation MLAAnsprenger, Christian, et al. "Potential of Immunotherapies in the Mediation of Antileukemic Responses for Patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) - With a Focus on Dendritic Cells of Leukemic Origin (DCleu)." Clinical Immunology (Orlando, Fla.), vol. 217, 2020, p. 108467.